Evaluating Clinical Pharmacy Services In A LEUKEMIA/BMT Medical Intervention Clinic: A Pilot Project

Warkentin, Dawn; Lacaria, Katie; Partovi, Nilufar; Berryman, Kay; Smith, Clay

doi:10.1016/j.bbmt.2008.12.476

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Two abstracts presented at a 2009 conference reported on developments in this area. These small studies reported improved patient medication reconciliation accuracy and reduction in the occurrence of adverse drug effects when a clinical pharmacist was involved in the clinic . These data were obtained from Canadian and US centres.…”

Section: Introductionmentioning

confidence: 99%

“…These small studies reported improved patient medication reconciliation accuracy and reduction in the occurrence of adverse drug effects when a clinical pharmacist was involved in the clinic. 8,9 These data were obtained from Canadian and US centres. To date, equivalent services have not been implemented in Australia, which presents an innovative research opportunity.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Implementation of a clinical pharmacy service to an allogeneic stem cell transplant ambulatory clinic

et al. 2014

View full text Add to dashboard Cite

Allogeneic stem cell transplantation (SCT) is a complex procedure that requires specialized medication management. Providing clinical pharmacy services in the ambulatory setting is warranted, as medications are a common source of confusion for SCT patients and their carers. These patients were routinely managed via traditional ambulatory dispensary services. The successful implementation of a clinical pharmacy service to the SCT unit ambulatory clinic allowed for regular contact and review by an experienced clinical pharmacist. This new service was evaluated within the context of a research project. The clinical pharmacist's presence in the ambulatory setting resulted in the identification and rectification of many medium to high risk medication related problems. The clinical pharmacist also contributed towards improved overall adherence. Other institutions are encouraged to implement and evaluate clinical pharmacy services to their ambulatory settings for SCT and other complex chronic patients.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%